Cart
sales@molnova.com
RS1-PDK1 inhibitor
CAS No. 1643958-85-3
RS1-PDK1 inhibitor( —— )
Catalog No. M34021 CAS No. 1643958-85-3
RS1-PDK1 inhibitor (RS 1) is a selective inhibitor of the protein kinase PDK1 that can be used to treat and prevent disease or disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 655 | In Stock |
|
| 10MG | 924 | In Stock |
|
| 25MG | 1359 | In Stock |
|
| 50MG | 1795 | In Stock |
|
| 100MG | 2446 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRS1-PDK1 inhibitor
-
NoteResearch use only, not for human use.
-
Brief DescriptionRS1-PDK1 inhibitor (RS 1) is a selective inhibitor of the protein kinase PDK1 that can be used to treat and prevent disease or disorders.
-
DescriptionRS1-PDK1 inhibitor (RS 1) is a selective inhibitor of the protein kinase PDK1 that can be used to treat and prevent disease or disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPDK
-
RecptorPDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1643958-85-3
-
Formula Weight380.89
-
Molecular FormulaC15H9ClN2O2S3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS(NC1=NC=2C(S1)=CC(Cl)=CC2)(=O)(=O)C=3C=4C(SC3)=CC=CC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
OSU-03013
OSU-03013 (OSU 03013, OSU03013) is a novel potent, orally active 3-phosphoinositide-dependent kinase-1 (PDK-1) with IC50 of 2 uM.
-
6-Bromo-4-methoxypyr...
6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile is a PDK1 inhibitor with anticancer and antiproliferative activity that can be used to study angiosarcoma, adenocarcinoma, multiple myeloma, psoriasis, prostate cancer, and Alzheimer's disease.
-
KPLH1130
KPLH1130 improves glucose tolerance in HFD-fed mice.?KPLH1130 is a specific pyruvate dehydrogenase kinase (PDK) inhibitor, blocks macrophage polarization and attenuates proinflammatory responses.
